However successful or high-achieving someone seems, you never know what problems or suffering they may have privately faced. When I was a schoolgirl in Dublin many years ago, the cleverest girl we ...
Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it ...
RESTORE-FA trial modifications build on positive four-week data; expect to share data based on 12 weeks of dosing in the first quarter of 2027 ...
WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 11, 2026, driven up by key catalysts such as positive quarterly or full year reports. Alamar Biosciences Inc. (ALMR ...
The 2027 MDA Clinical & Scientific Conference will be held March 21–24, 2027, at Rosen Shingle Creek in Orlando, Florida 2027 MDA Clinical & Scientific Conference - Registration Now Open Registration ...
Acacia Research Corp. () has held its Q2 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks. Unlock powerful investing tools with Tip ...
GlobalData on MSN
DSMB approves dose escalation in PepGen’s FREEDOM2-DM1 study
Safety analysis of the fully enrolled 10mg/kg cohort and the OLE prompted the recommendations.
Sarepta Therapeutics (SRPT) is seeing a new strategic focus under its recently appointed CEO, with more attention shifting to experimental RNA therapies, drugs designed to modify ...
It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results